Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 62,762 | 48,432 | 42,522 | 49,326 | 46,185 |
| Cost of Goods | 26,179 | 23,489 | 29,881 | 27,057 | 29,471 |
| Gross Profit | 36,583 | 24,943 | 12,641 | 22,269 | 16,714 |
| Operating Expenses | 32,699 | 28,824 | 27,413 | 25,934 | 29,161 |
| Operating Income | 4,063 | -3,392 | -13,891 | -3,608 | -11,976 |
| Other Income | -10,671 | -12,535 | -31,260 | -5,042 | -9,328 |
| Pre-tax Income | -6,608 | -15,927 | -45,151 | -8,650 | -21,304 |
| Income Tax | 191 | 610 | 1,839 | 1,821 | -3,135 |
| Net Income Continuous | -6,799 | -16,537 | -46,990 | -10,471 | -18,169 |
| Net Income | $-6,799 | $-16,537 | $-46,990 | $-10,471 | $-18,169 |
| EPS Basic Total Ops | -0.20 | -0.45 | -1.40 | -0.35 | -0.60 |
| EPS Basic Continuous Ops | -0.19 | -0.46 | -1.44 | -0.33 | -0.59 |
| EPS Diluted Total Ops | -0.20 | -0.45 | -1.40 | -0.35 | -0.60 |
| EPS Diluted Continuous Ops | -0.19 | -0.46 | -1.44 | -0.33 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.04 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $15,339 | $8,617 | $3,863 | $11,998 | $6,002 |